{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:29:27Z","timestamp":1787020167550,"version":"build-2736575974"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,5,16]],"date-time":"2023-05-16T00:00:00Z","timestamp":1684195200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,5,16]],"date-time":"2023-05-16T00:00:00Z","timestamp":1684195200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      <jats:italic>Saccharomyces cerevisiae<\/jats:italic>\n                      is ubiquitous in the gastrointestinal tract and known as brewer's or baker's yeast. We experienced a case of\n                      <jats:italic>S. cerevisiae<\/jats:italic>\n                      and\n                      <jats:italic>Candida glabrata<\/jats:italic>\n                      co-infectious bloodstream infection\n                      <jats:italic>.<\/jats:italic>\n                      It is rare to detect both\n                      <jats:italic>S. cerevisiae<\/jats:italic>\n                      and\n                      <jats:italic>Candida<\/jats:italic>\n                      species in blood cultures together.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Case<\/jats:title>\n                    <jats:p>\n                      We treated a 73-year-old man who developed a pancreaticoduodenal fistula infection after pancreaticoduodenectomy. The patient had a fever on postoperative day 59. We took blood cultures and detected\n                      <jats:italic>C. glabrata<\/jats:italic>\n                      . Thus, we started micafungin. On postoperative day 62, we retested blood cultures, and detected\n                      <jats:italic>S cerevisiae<\/jats:italic>\n                      and\n                      <jats:italic>C. glabrata<\/jats:italic>\n                      . We changed micafungin to liposomal amphotericin B. Blood cultures became negative on postoperative day 68. We changed liposomal amphotericin B to fosfluconazole and micafungin because of hypokalemia. He got well, and we terminated antifungal drugs 18\u00a0days after the blood cultures became negative.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>\n                      Co-infection with\n                      <jats:italic>S. cerevisiae<\/jats:italic>\n                      and\n                      <jats:italic>Candida<\/jats:italic>\n                      species is rare. In addition, in this case,\n                      <jats:italic>S. cerevisiae<\/jats:italic>\n                      developed from blood cultures during micafungin administration. Thus, micafungin may not be effective enough to treat\n                      <jats:italic>S. cerevisiae<\/jats:italic>\n                      fungemia, although echinocandin is considered one of the alternative therapy for\n                      <jats:italic>Saccharomyces<\/jats:italic>\n                      infections.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12879-023-08287-9","type":"journal-article","created":{"date-parts":[[2023,5,16]],"date-time":"2023-05-16T05:02:38Z","timestamp":1684213358000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["A case of bloodstream co-infection of Saccharomyces cerevisiae and Candida glabrata while using micafungin"],"prefix":"10.1186","volume":"23","author":[{"given":"Kento","family":"Furuya","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenta","family":"Ito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyohei","family":"Sugiyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Tokuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideyuki","family":"Kanemoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsuhiko","family":"Kamei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshio","family":"Shimada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,5,16]]},"reference":[{"key":"8287_CR1","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1101\/gr.2114704","volume":"14","author":"LC Edwards-Ingram","year":"2004","unstructured":"Edwards-Ingram LC, Gent ME, Hoyle DC, Hayes A, Stateva LI, Oliver SG. Comparative genomic hybridization provides new insights into the molecular taxonomy of the Saccharomyces sensu stricto complex. Genome Res. 2004;14:1043\u201351.","journal-title":"Genome Res"},{"key":"8287_CR2","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1086\/518175","volume":"44","author":"J Jensen","year":"2007","unstructured":"Jensen J, Mu\u00f1oz P, Guinea J, Rodr\u00edguez-Cr\u00e9ixems M, Pel\u00e1ez T, Bouza E. Mixed fungemia: incidence, risk factors, and mortality in a general hospital. Clin Infect Dis. 2007;44:109\u201314.","journal-title":"Clin Infect Dis"},{"key":"8287_CR3","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1086\/429916","volume":"40","author":"P Mu\u00f1oz","year":"2005","unstructured":"Mu\u00f1oz P, Bouza E, Cuenca-Estrella M, Eiros JM, P\u00e9rez MJ, S\u00e1nchez-Somolinos M, et al. Saccharomyces cerevisiae fungemia: an emerging infectious disease. Clin Infect Dis. 2005;40:1625\u201334.","journal-title":"Clin Infect Dis"},{"key":"8287_CR4","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1186\/s13054-020-2766-1","volume":"24","author":"J Poissy","year":"2020","unstructured":"Poissy J, Damonti L, Bignon A, Khanna N, Kietzell MV, Boggian K, et al. Risk factors for candidemia: a prospective matched case-control study. Crit Care. 2020;24:109.","journal-title":"Crit Care"},{"key":"8287_CR5","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.1086\/429926","volume":"40","author":"R Herbrecht","year":"2005","unstructured":"Herbrecht R, Nivoix Y. Saccharomyces cerevisiae Fungemia: An Adverse Effect of Saccharomyces boulardii Probiotic Administration. Clin Infect Dis. 2005;40:1635\u20137.","journal-title":"Clin Infect Dis"},{"key":"8287_CR6","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/S1473-3099(21)00203-6","volume":"21","author":"SCA Chen","year":"2021","unstructured":"Chen SCA, Perfect J, Colombo AL, Cornely OA, Groll AH, Seidel D, et al. Global guideline for the diagnosis and management of rare yeast infections: an initiative of the ECMM in cooperation with ISHAM and ASM. Lancet Infect Dis. 2021;21:375-e386.","journal-title":"Lancet Infect Dis"},{"key":"8287_CR7","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.mmcr.2017.02.002","volume":"15","author":"S At\u0131c\u0131","year":"2017","unstructured":"At\u0131c\u0131 S, Soysal A, KaradenizCerit K, Y\u0131lmaz \u015e, Aksu B, K\u0131yan G, et al. Catheter-related Saccharomyces cerevisiae Fungemia Following Saccharomyces boulardii Probiotic Treatment: In a child in intensive care unit and review of the literature. Med Mycol Case Rep. 2017;15:33\u20135.","journal-title":"Med Mycol Case Rep"},{"key":"8287_CR8","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1111\/j.1365-2141.2012.09212.x","volume":"158","author":"G Choi","year":"2012","unstructured":"Choi G, Meijer SL, Hazenberg MD. Disseminated bread yeast fungaemia in a baker\u2019s wife with acute myeloid leukaemia. Br J Haematol. 2012;158:298.","journal-title":"Br J Haematol"},{"key":"8287_CR9","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.mmcr.2018.11.003","volume":"23","author":"M Fadhel","year":"2018","unstructured":"Fadhel M, Patel S, Liu E, Levitt E, Asif A. Saccharomyces cerevisiae fungemia in a critically ill patient with acute cholangitis and long term probiotic use. Med Mycol Case Rep. 2018;23:23\u20135.","journal-title":"Med Mycol Case Rep"},{"key":"8287_CR10","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1186\/cc6843","volume":"12","author":"N Lolis","year":"2008","unstructured":"Lolis N, Veldekis D, Moraitou H, Kanavaki S, Velegraki A, Triandafyllidis C, et al. Saccharomyces boulardii fungaemia in an intensive care unit patient treated with caspofungin. Crit Care. 2008;12:414.","journal-title":"Crit Care"},{"key":"8287_CR11","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1186\/s12866-014-0305-4","volume":"14","author":"R Bojsen","year":"2014","unstructured":"Bojsen R, Regenberg B, Folkesson A. Saccharomyces cerevisiae biofilm tolerance towards systemic antifungals depends on growth phase. BMC Microbiol. 2014;14:305.","journal-title":"BMC Microbiol"},{"key":"8287_CR12","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1007\/s40262-017-0578-5","volume":"57","author":"RE Wasmann","year":"2018","unstructured":"Wasmann RE, Muilwijk EW, Burger DM, Verweij PE, Knibbe CA, Br\u00fcggemann RJ. Clinical Pharmacokinetics and Pharmacodynamics of Micafungin. Clin Pharmacokinet. 2018;57:267\u201386.","journal-title":"Clin Pharmacokinet."},{"key":"8287_CR13","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1086\/517685","volume":"27","author":"I Fredenucci","year":"1998","unstructured":"Fredenucci I, Chomarat M, Boucaud C, Flandrois JP. Saccharomyces boulardii fungemia in a patient receiving Ultra-levure therapy. Clin Infect Dis. 1998;27:222\u20133.","journal-title":"Clin Infect Dis"},{"key":"8287_CR14","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1007\/s001340051261","volume":"26","author":"BJ Rijnders","year":"2000","unstructured":"Rijnders BJ, Van Wijngaerden E, Verwaest C, Peetermans WE. Saccharomyces fungemia complicating Saccharomyces boulardii treatment in a non-immunocompromised host. Intensive Care Med. 2000;26:825.","journal-title":"Intensive Care Med"},{"key":"8287_CR15","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1007\/s100960050003","volume":"19","author":"C Hennequin","year":"2000","unstructured":"Hennequin C, Kauffmann-Lacroix C, Jobert A, Viard JP, Ricour C, Jacquemin JL, et al. Possible role of catheters in Saccharomyces boulardii fungemia. Eur J Clin Microbiol Infect Dis. 2000;19:16\u201320.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"8287_CR16","doi-asserted-by":"publisher","first-page":"5340","DOI":"10.1128\/JCM.41.11.5340-5343.2003","volume":"41","author":"M Sassone","year":"2003","unstructured":"Sassone M, Serra P, Mondello F, Girolamo A, Scafetti S, Pistella E, et al. Outbreak of Saccharomyces cerevisiae subtype boulardii fungemia in patients neighboring those treated with a probiotic preparation of the organism. J Clin Microbiol. 2003;41:5340\u20133.","journal-title":"J Clin Microbiol"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-023-08287-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-023-08287-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-023-08287-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,16]],"date-time":"2023-05-16T05:02:39Z","timestamp":1684213359000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-023-08287-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,16]]},"references-count":16,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["8287"],"URL":"https:\/\/doi.org\/10.1186\/s12879-023-08287-9","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,16]]},"assertion":[{"value":"14 August 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 April 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 May 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The patient provided written informed consent for the personal, clinical information and images anonymized in this study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"329"}}